| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,711 |
20,874 |
$2.44M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,337 |
17,334 |
$2.25M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,516 |
7,957 |
$1.19M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,265 |
6,070 |
$570K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,708 |
7,211 |
$380K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,234 |
2,133 |
$353K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,968 |
2,859 |
$301K |
| 70450 |
Computed tomography, head or brain; without contrast material |
883 |
813 |
$206K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,241 |
1,424 |
$203K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
732 |
688 |
$179K |
| 80053 |
Comprehensive metabolic panel |
14,245 |
13,230 |
$168K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
371 |
350 |
$128K |
| G0378 |
Hospital observation service, per hour |
2,263 |
1,039 |
$111K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,973 |
2,723 |
$96K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,976 |
2,726 |
$67K |
| 62323 |
|
134 |
131 |
$63K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,448 |
5,619 |
$59K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,031 |
2,897 |
$58K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
377 |
365 |
$56K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
861 |
238 |
$52K |
| 84702 |
|
1,814 |
1,621 |
$47K |
| 84484 |
|
7,076 |
4,445 |
$44K |
| 36415 |
Collection of venous blood by venipuncture |
35,649 |
30,663 |
$42K |
| 87480 |
|
2,071 |
1,907 |
$38K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
149 |
142 |
$32K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,679 |
1,565 |
$32K |
| 87510 |
|
2,071 |
1,907 |
$32K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
854 |
813 |
$29K |
| 87660 |
|
2,094 |
1,929 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,016 |
19,889 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
228 |
223 |
$27K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
158 |
151 |
$25K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
852 |
822 |
$21K |
| 80061 |
Lipid panel |
1,344 |
1,310 |
$21K |
| 62327 |
|
73 |
70 |
$20K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,329 |
1,260 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,207 |
1,161 |
$17K |
| 84439 |
|
657 |
640 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,170 |
2,964 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
3,707 |
3,446 |
$11K |
| 85027 |
|
1,237 |
1,164 |
$11K |
| 81001 |
|
8,847 |
8,315 |
$10K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
391 |
380 |
$10K |
| 86780 |
|
444 |
386 |
$9K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
39 |
37 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,612 |
6,871 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
345 |
338 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,891 |
8,337 |
$7K |
| 87070 |
|
363 |
314 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
414 |
365 |
$5K |
| 83880 |
|
591 |
539 |
$5K |
| 82607 |
|
218 |
210 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
4,221 |
4,002 |
$5K |
| 87340 |
|
277 |
238 |
$5K |
| 59025 |
Fetal non-stress test |
63 |
41 |
$4K |
| 86900 |
|
260 |
226 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,258 |
1,223 |
$4K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$4K |
| 82746 |
|
220 |
211 |
$4K |
| 86850 |
|
275 |
240 |
$3K |
| 83874 |
|
242 |
166 |
$3K |
| 76801 |
|
15 |
13 |
$2K |
| 86762 |
|
127 |
106 |
$2K |
| 86803 |
|
56 |
56 |
$2K |
| 80076 |
|
357 |
322 |
$2K |
| 86901 |
|
260 |
226 |
$2K |
| 84481 |
|
167 |
158 |
$2K |
| 83690 |
|
5,668 |
5,302 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
438 |
434 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,384 |
1,040 |
$2K |
| 82947 |
|
313 |
220 |
$2K |
| 83735 |
|
1,825 |
1,662 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,237 |
3,875 |
$1K |
| 84703 |
|
3,674 |
3,469 |
$1K |
| 85379 |
|
230 |
220 |
$1K |
| 80320 |
|
129 |
122 |
$999.79 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$976.12 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
44 |
44 |
$951.82 |
| 87081 |
|
59 |
57 |
$872.71 |
| 86787 |
|
28 |
28 |
$834.78 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$779.20 |
| 76818 |
|
17 |
12 |
$776.91 |
| 85610 |
|
955 |
863 |
$645.43 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
345 |
175 |
$540.54 |
| 84403 |
|
27 |
27 |
$501.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,076 |
1,578 |
$478.84 |
| 84436 |
|
17 |
17 |
$386.16 |
| 81025 |
|
1,598 |
1,504 |
$379.52 |
| 83605 |
|
89 |
76 |
$376.86 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
394 |
383 |
$368.60 |
| 86317 |
|
14 |
13 |
$297.60 |
| 86376 |
|
12 |
12 |
$267.22 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,368 |
4,872 |
$264.64 |
| 85730 |
|
604 |
564 |
$223.79 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
505 |
499 |
$199.71 |
| 81003 |
|
574 |
548 |
$198.15 |
| 82950 |
|
26 |
25 |
$194.26 |
| 84480 |
|
17 |
17 |
$193.03 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,606 |
3,365 |
$191.84 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,348 |
3,014 |
$140.78 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,439 |
2,271 |
$102.68 |
| J2704 |
Injection, propofol, 10 mg |
2,040 |
1,857 |
$97.66 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
717 |
677 |
$87.46 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
340 |
303 |
$75.13 |
| 86140 |
|
134 |
130 |
$56.29 |
| 80143 |
|
43 |
40 |
$34.99 |
| 88342 |
|
15 |
12 |
$23.16 |
| 80179 |
|
43 |
40 |
$17.49 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
405 |
307 |
$17.42 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
798 |
749 |
$10.00 |
| 83615 |
|
116 |
113 |
$7.15 |
| J1630 |
Injection, haloperidol, up to 5 mg |
62 |
58 |
$4.19 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
243 |
222 |
$3.26 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
642 |
549 |
$0.95 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
24 |
24 |
$0.66 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
29 |
25 |
$0.55 |
| 87807 |
|
15 |
15 |
$0.00 |
| 96376 |
|
121 |
55 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
12 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
99 |
81 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
30 |
26 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
34 |
21 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
52 |
43 |
$0.00 |
| 00813 |
|
25 |
25 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
58 |
56 |
$0.00 |
| 88304 |
|
12 |
12 |
$0.00 |
| 74022 |
|
13 |
12 |
$0.00 |
| 94664 |
|
41 |
39 |
$0.00 |
| 99152 |
|
72 |
66 |
$0.00 |
| 00731 |
|
25 |
24 |
$0.00 |
| 73630 |
|
27 |
25 |
$0.00 |
| 00811 |
|
57 |
55 |
$0.00 |